Bruce N. Jacobs - 27 Jun 2024 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role: Chief Financial Officer
Signature: /s/ Bruce N. Jacobs
Issuer symbol: KYMR
Transactions as of: 27 Jun 2024
Net transactions value: +$52,000
Form type: 4
Filing time: 28 Jun 2024, 08:30:03 UTC
Previous filing: 04 Mar 2024
Next filing: 13 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KYMR	Common Stock	Options Exercise	$52,000	+25,000	+17%	$2.08^*	168,554	27 Jun 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KYMR	Stock Option (Right to Buy)	Options Exercise	$0	-25,000	-19%	$0.000000	104,899	27 Jun 2024	Common Stock	25,000	$2.08	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This number includes 1,203 shares acquired under the Registrant's employee stock purchase plan on June 1, 2024.
F2	Twenty-five percent (25%) of the shares underlying this stock option vested on July 1, 2020 and the remaining shares shall vest in equal monthly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.